We chose four mesenchymal transition markers (N-cadherin, ZEB1, Slug, and CD44) from the gene list identified by GSEA, which are reported to be involved in glioma mesenchymal transition [6, 32–35], and analyzed the relationship between these markers and PBX3 expression. This evidence concerns the gene CD44 and central nervous system cancer.